Current Practical Guidelines for the Most Common Nuclear Medicine Procedures
- PDF / 735,267 Bytes
- 40 Pages / 595.276 x 790.866 pts Page_size
- 22 Downloads / 277 Views
46
Irene Marini, Onelio Geatti, and H. William Strauss
Contents 46.1 L ymphoscintigraphy for Radio-Guided Sentinel Lymph Node Biopsy in Patients with Breast Cancer 46.1.1 Indications 46.1.2 Procedure 46.1.3 Precautions 46.1.4 Radiopharmaceuticals 46.1.5 Volume and Activity 46.1.6 Modality of Injection 46.1.7 Image Acquisition 46.1.8 Radioguided Surgery 46.1.9 Interpretation Criteria 46.1.10 Reporting
1102 1103 1103 1103 1103 1103 1103 1103 1103 1104 1104
46.2 L ymphoscintigraphy for Radioguided Sentinel Lymph Node Biopsy in Patients with Cutaneous Melanoma 46.2.1 Potential Contraindications 46.2.2 Procedure 46.2.3 Radiopharmaceuticals 46.2.4 Administration of Radiopharmaceutical 46.2.5 Image Acquisition 46.2.6 Dynamic Imaging 46.2.7 Early Static Images 46.2.8 Delayed Static Images 46.2.9 SPECT/CT 46.2.10 Image Interpretation and Report 46.2.11 Pitfalls 46.2.12 Sources of False-Negative Interpretation of Images 46.2.13 Procedure in the Operating Room 46.2.14 Gamma Probe 46.2.15 Possible Causes of False-Negative Results
1104 1104 1104 1104 1104 1105 1105 1105 1105 1105 1105 1105 1106 1106 1106 1106
46.3 [18F]FDG PET/CT in Oncology 46.3.1 Common Clinical Indications for [18F]FDG PET/CT in Malignant Diseases 46.3.2 Procedure/Specification of the [18F]FDG PET/CT Scan
1106 1106 1107
I. Marini Nuclear Medicine Institute, Università Cattolica del Sacro Cuore and Nuclear Medicine Center, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy O. Geatti (*) Nuclear Medicine Center, University Hospital of Udine, Udine, Italy H. W. Strauss Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA © Springer Nature Switzerland AG 2019 D. Volterrani et al. (eds.), Nuclear Medicine Textbook, https://doi.org/10.1007/978-3-319-95564-3_46
1099
1100
I. Marini et al. 46.3.3 Instructions to Patients 46.3.4 Image Acquisition 46.3.5 CT Protocols for [18F]FDG PET/CT Studies
1107 1107 1107
46.4 Perfusion Brain SPECT 46.4.1 Common Clinical Indication for a Perfusion Brain SPECT Study 46.4.2 Instructions to Patients 46.4.3 Practical Instructions About Tracer Injection and Uptake Period 46.4.4 Image Acquisition 46.4.5 Reconstruction and Analysis
1107 1108 1108 1108 1108 1108
46.5 Brain SPECT with 123I-Labelled Dopamine Transporter Ligands 46.5.1 Common Clinical Indication for a Dopamine Receptor Brain SPECT Study 46.5.2 Instructions to Patients 46.5.3 Practical Instructions About Tracer Injection and Uptake Period 46.5.4 Image Acquisition 46.5.5 Reconstruction and Analysis
1108 1109 1109 1109 1109 1109
46.6 SPECT and PET with Dopamine D2 Receptor Ligands 46.6.1 Most Common Indication 46.6.2 Less Common Indications 46.6.3 Contraindications 46.6.4 Procedure 46.6.5 Timing of Injection 46.6.6 Administered Activity to Adul
Data Loading...
